Consolidated Statements of Income (Loss) - USD ($) shares in Thousands, $ in Thousands	3 Months Ended
	Mar. 31, 2016	Mar. 31, 2015
Revenues:
Product sales and services	$ 35,353	$ 32,726
License and research revenue	863	0
Total	36,216	32,726
Operating expenses:
Cost of products and services sold	4,395	3,630
Research and development expenses	5,388	6,022
Selling, general and administrative expenses	9,461	4,463
Intangible asset amortization	3,514	3,143
Changes in fair value of related party acquisition-related contingent consideration	7,916	5,254
Total	30,674	22,512
Operating income	5,542	10,214
Investment Income	200	664
Interest Expense	(175)	0
Interest Expense - changes in fair value of related party financing-relatedcontingent consideration	(1,861)	(259)
Foreign exchange gain (loss)	(2,941)	11,501
Income before income taxes	765	22,120
Income tax provision	7,141	10,473
Net income (loss)	$ (6,376)	$ 11,647
Earnings (loss) per share - Basic:
Net income (loss) per share - Basic (in dollars per share)	$ (0.15)	$ 0.29
Earnings (loss) per share - Diluted:
Net income (loss) per share - Diluted (in dollars per share)	$ (0.15)	$ 0.27
Earnings (loss) per share
Weighted average number of shares outstanding - Basic (in shares)	41,241	40,207
Weighted average number of shares outstanding - Diluted (in shares)	41,241	42,879